AbbVie’s Rinvoq Shines In First Of Three Eczema Pivotal Studies

 
• By Joseph Haas
  
business man show increase market share, growth of profit
AbbVie took a step toward adding atopic dermatitis to Rinvoq's label

More from Clinical Trials

More from R&D